Friday, October 9, 2020

Next generation sequencing (NGS) Market Size, Competitive Strategies, Application Analysis, Regional, and Forecasts 2019 To 2030

The advent of NGS has led to significant changes in the scientific approach utilized for both clinical and research applications. Both RNA & DNA sequencing have been proven to be extremely useful for studying evolutionary relationships, mutation, sequence variation and other vital information associated with genes. The clinical applications of which has been pivotal in diagnosing germline diseases and understanding the genetic basis of various hereditary or chronic diseases among others. The growing incidences of several clinical ailments has directly contributed to the extensive adoption of NGS and other sequencing techniques, to obtain better understanding of the diseases and formulate necessary therapies for the same.

The Next generation sequencing (NGS) Market is segmented on the basis of Services, Technology, Application and region.

Major Services of Next generation sequencing (NGS) Market covered are:

  • Pre-Sequencing Products & Service
  • Sequencing Services
  • Data Analysis
  • Storage
  • Management

Major Technology of Next generation sequencing (NGS) Market covered are:

  • Sequencing By Synthesis Ion Semiconductor Sequencing
  • Single-Molecule Real-Time Sequencing

Major Services of Next generation sequencing (NGS) Market covered are:

  • Diagnostics
  • Drug Discovery

Improvement in the overall NGS technology in terms of pipeline analyses, sequencing chemistry, data interpretation, reliability and costs has led to application of the technique in several fields of medical sciences, including oncology. The utilization of NGS technologies provides accurate and deeper knowledge regarding molecular basis of individual tumors, thereby providing a better, efficient and long lasting treatment option. According to Cancer Research UK, the number of cancer cases reported worldwide in the year 2018, was approximately around 17 million. It is further projected that within the period 2018-2040, the total incidence rate of worldwide cancer will increment by 62%. The growing incidences of cancer are anticipated to present a lucrative growth opportunity for the global Next generation sequencing (NGS) market in the coming years.

Read More @ https://www.medgadget.com/2020/08/next-generation-sequencing-ngs-market-size-competitive-strategies-application-analysis-regional-and-forecasts-2019-to-2030.html



No comments:

Post a Comment